Final Terms

Summary by AI ^BETAClose X

Mitsubishi Corporation has published final terms for the issuance of €500,000,000 of 2.750 per cent. Notes due 2030 and €500,000,000 of 3.375 per cent. Notes due 2034, collectively totaling €1,000,000,000. These notes are being issued under the Mitsubishi Corporation and Mitsubishi Corporation Finance PLC U.S.$5,000,000,000 Euro Medium Term Note Programme.

Disclaimer*

Mitsubishi Corporation

25 February 2026

MITSUBISHI CORPORATION - Publication of Final Terms

The following final terms are available for viewing:

Final Terms dated 24 February 2026 in respect of an issue by Mitsubishi Corporation of €500,000,000 2.750 per cent. Notes due 2030 and €500,000,000 3.375 per cent. Notes due 2034 (together, the "Notes")

The Notes are issued under the MITSUBISHI CORPORATION and MITSUBISHI CORPORATION FINANCE PLC U.S.$5,000,000,000 Euro Medium Term Note Programme

To view the relevant Final Terms, please paste the following URL into the address bar of your browser.

http://www.rns-pdf.londonstockexchange.com/rns/3273U_1-2026-2-25.pdf

http://www.rns-pdf.londonstockexchange.com/rns/3273U_2-2026-2-25.pdf

DISCLAIMER - INTENDED ADDRESSEES

Please note that the information contained in the relevant Final Terms and the related Offering Circular may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Offering Circular) only and not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the relevant Final Terms is not addressed. Prior to relying on the information contained in the relevant Final Terms, you must ascertain whether or not you are part of the intended addressees of the information contained therein.

Your right to access this service is conditional upon complying with the above requirement.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END